search
Back to results

Effect of RIPC on the Prevention of POD in Patients Undergoing Cardiac Surgery

Primary Purpose

Postoperative Delirium, Cardiac Surgery

Status
Not yet recruiting
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
RIPC induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusion
Sponsored by
Shanghai Zhongshan Hospital
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Postoperative Delirium

Eligibility Criteria

18 Years - 80 Years (Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • patients undergoing elective cardiac surgery;
  • age ≥ 18 yr;
  • any sex;
  • American Society of Anesthesiologists (ASA) class ≥II class;
  • New York Heart Association (NYHA) ≥II class.

Exclusion Criteria:

  • emergency surgery;
  • a history of cardiovascular surgery;
  • peripheral vascular disease affecting the upper limbs;
  • acute myocardial infarction (MI) up to 14 days before surgery;
  • a history of severe injuries and operations within 3 months before cardiac surgery;
  • a history of cancer and chronic autoimmune diseases.

Sites / Locations

    Arms of the Study

    Arm 1

    Arm 2

    Arm Type

    Experimental

    No Intervention

    Arm Label

    RIPC

    Con

    Arm Description

    RIPC was induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusion on the upper arm. By using blood pressure cuff inflation, patients in the RIPC group were exposed to a pressure 50 mmHg higher than the systolic radial artery pressure baseline.

    The control group had a deflated cuff placed on the upper arm for the same time.

    Outcomes

    Primary Outcome Measures

    Incidence of postoperative delirium
    Patients were assessed for postoperative delirium by the Confusion Assessment Method (CAM) from the time they were transferred to the ICU at the end of surgery until 7 days postoperatively or before discharge, whichever came first

    Secondary Outcome Measures

    Full Information

    First Posted
    June 22, 2022
    Last Updated
    June 29, 2022
    Sponsor
    Shanghai Zhongshan Hospital
    search

    1. Study Identification

    Unique Protocol Identification Number
    NCT05434455
    Brief Title
    Effect of RIPC on the Prevention of POD in Patients Undergoing Cardiac Surgery
    Official Title
    Effects of Remote Ischemic Preconditioning(RIPC) on the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery: A Pilot Randomized Clinical Trial
    Study Type
    Interventional

    2. Study Status

    Record Verification Date
    June 2022
    Overall Recruitment Status
    Not yet recruiting
    Study Start Date
    July 1, 2022 (Anticipated)
    Primary Completion Date
    July 14, 2022 (Anticipated)
    Study Completion Date
    December 31, 2023 (Anticipated)

    3. Sponsor/Collaborators

    Responsible Party, by Official Title
    Sponsor
    Name of the Sponsor
    Shanghai Zhongshan Hospital

    4. Oversight

    Studies a U.S. FDA-regulated Drug Product
    No
    Studies a U.S. FDA-regulated Device Product
    No

    5. Study Description

    Brief Summary
    Postoperative delirium (POD) is one of the most frequent neurological complications in elderly patients and is closely associated with longer ICU stay and hospitalization, deterioration of long-term neurocognitive function, and increased mortality. The incidence of POD is significantly higher in elderly patients undergoing cardiac surgery than in other populations. Therefore, the prevention of POD is an important clinical problem to be solved urgently. In this study, we intend to observe the effect of RIPC on the prevention and treatment of POD in patients undergoing cardiac surgery through a prospective randomized controlled trial.

    6. Conditions and Keywords

    Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
    Postoperative Delirium, Cardiac Surgery

    7. Study Design

    Primary Purpose
    Prevention
    Study Phase
    Not Applicable
    Interventional Study Model
    Single Group Assignment
    Masking
    Participant
    Allocation
    Randomized
    Enrollment
    216 (Anticipated)

    8. Arms, Groups, and Interventions

    Arm Title
    RIPC
    Arm Type
    Experimental
    Arm Description
    RIPC was induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusion on the upper arm. By using blood pressure cuff inflation, patients in the RIPC group were exposed to a pressure 50 mmHg higher than the systolic radial artery pressure baseline.
    Arm Title
    Con
    Arm Type
    No Intervention
    Arm Description
    The control group had a deflated cuff placed on the upper arm for the same time.
    Intervention Type
    Device
    Intervention Name(s)
    RIPC induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusion
    Intervention Description
    RIPC was induced with 3 cycles of 5 minutes of ischaemia and 5 minutes of reperfusion on the upper arm. By using blood pressure cuff inflation, patients in the RIPC group were exposed to a pressure 50 mmHg higher than the systolic radial artery pressure baseline.
    Primary Outcome Measure Information:
    Title
    Incidence of postoperative delirium
    Description
    Patients were assessed for postoperative delirium by the Confusion Assessment Method (CAM) from the time they were transferred to the ICU at the end of surgery until 7 days postoperatively or before discharge, whichever came first
    Time Frame
    7 days postoperatively or before discharge, whichever came first

    10. Eligibility

    Sex
    All
    Minimum Age & Unit of Time
    18 Years
    Maximum Age & Unit of Time
    80 Years
    Accepts Healthy Volunteers
    No
    Eligibility Criteria
    Inclusion Criteria: patients undergoing elective cardiac surgery; age ≥ 18 yr; any sex; American Society of Anesthesiologists (ASA) class ≥II class; New York Heart Association (NYHA) ≥II class. Exclusion Criteria: emergency surgery; a history of cardiovascular surgery; peripheral vascular disease affecting the upper limbs; acute myocardial infarction (MI) up to 14 days before surgery; a history of severe injuries and operations within 3 months before cardiac surgery; a history of cancer and chronic autoimmune diseases.

    12. IPD Sharing Statement

    Plan to Share IPD
    Undecided

    Learn more about this trial

    Effect of RIPC on the Prevention of POD in Patients Undergoing Cardiac Surgery

    We'll reach out to this number within 24 hrs